Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

04-18-2018 | Type 2 diabetes | Review | Article

Pediatric Type 2 Diabetes in Japan: Similarities and Differences from Type 2 Diabetes in Other Pediatric Populations

Journal: Current Diabetes Reports

Author: Tatsuhiko Urakami

Publisher: Springer US

Login to get access

Abstract

Purpose of Review

To review clinical characteristics of pediatric type 2 diabetes in Japan.

Recent Findings

It is well recognized that Asian populations, particularly the Japanese, have a higher incidence of childhood type 2 diabetes. Of note, most Asian populations show a higher incidence of pediatric type 2 diabetes than that of type 1 diabetes. However, a current report in the USA demonstrated a dramatic increase in the incidence of young people with type 2 diabetes in recent years. The USA could have a much higher incidence of type 2 diabetes than Japan, possibly due to environmental and behavioral factors. The clinical features of Japanese young people with type 2 diabetes might have some differences from type 2 diabetes in other pediatric populations. Japanese children with type 2 diabetes are likely to be thinner than Caucasian children. Approximately 10–15% Japanese patients with type 2 diabetes exhibit normal weight with milder insulin resistance and substantial insulin secretion failure. Autoimmunity is not associated with the etiology of type 2 diabetes.

Summary

Some genetic background and environmental factors, different from those in Caucasians, could play a role in the development of type 2 diabetes in Japanese children. Considering these characteristics, we must consider adequate therapy and management for young people with type 2 diabetes.
Literature
1.
•• Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Bartleft T, et al. Type 2 diabetes in the child and adolescent. ISPAD clinical practice consensus guidelines 2014 compendium. Pediatr Diabetes. 2014;15(Suppl. 20):26–40. This study provides ISPAD proposed Clinical Practice Consensus Guideline for clinical manifestations, diagnosis and treatment in children and adolescents with type 2 diabetes. This Guideline is adapted worldwide. CrossRefPubMed
2.
Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159–67. CrossRefPubMed
3.
Ogihara T, Mirmira RG. An islet in distress: β cell failure in type 2 diabetes. J Diabetes Investig. 2010;1:123–33. PubMedPubMedCentral
4.
American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;205:671–80. CrossRef
5.
Copeland KC, Silverstein J, Moore KR, Prazar GE, Raymer T, Shiffman RN, et al. Management of newly diagnosed type 2 diabetes in children and adolescents. Pediatrics. 2013;131:364–82. CrossRefPubMed
6.
• Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC. Definition, epidemiology, and classification of diabetes in children and adolescents. ISPAD clinical practice consensus guidelines 2014 compendium. Pediatr Diabetes. 2014;15(Suppl. 20):4–17. This study provides ISPAD proposed Clinical Practice Consensus Guideline for definition, epidemiology, and classification of diabetes in children and adolescents. This Guideline is adapted worldwide. CrossRefPubMed
7.
Debelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311:1778–86. CrossRef
8.
Urakami T, Kubota S, Nitadori Y, Harada K, Owada M, Kitagawa T. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care. 2005;28:1876–81. CrossRefPubMed
9.
Urakami T, Morimoto S, Nitadori Y, Harada K, Owada M, Kitagawa T. Urine glucose screening program at schools in Japan to detect children with diabetes and its outcome-incidence and clinical characteristics of childhood type 2 diabetes in Japan. Pediatr Res. 2007;61:141–5. CrossRefPubMed
10.
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl. 1): S13-S27.
11.
Kida K, Mimura G, Ito T, Murakami K, Ashkenazi I, Laron Z. Incidence of type 1 diabetes in children aged 0–14 in Japan, 1986–1990, including an analysis for seasonality of onset and month of birth: JDS study. The data Committee for Childhood Diabetes of the Japan Diabetes Society (JDS). Diabet Med. 2000;17:59–63. CrossRefPubMed
12.
Urakami T, Suzuki J, Mugishima H, Amemiya S, Sugihara S, Kawamura T, et al. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. Pediatr Endocrinol Rev. 2012;10(Suppl. 1):51–61. PubMed
13.
• Mayer-Davis EJ, Lawrence JM, Debelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med. 2017;376:1419–29. This study provides current incidence trends of young people with type 1 and type 2 diabetes among various ethnic groups and races. CrossRefPubMedPubMedCentral
14.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806–14. CrossRefPubMedPubMedCentral
15.
Urakami T. Increased trend in the incidence of diabetes among youth in the USA during 2002-2012. J Diabetes Investig. 2017;8:748–9. CrossRefPubMedPubMedCentral
16.
Low LCK. The epidemic of type 2 diabetes mellitus in the Asia-pacific region. Pediatr Diabetes. 2010;11:212–5. CrossRefPubMed
17.
Yamanouchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-deprived hormone adiponectin reverses insulin resistance associate with both lipoatrophy and obesity. Nat Med. 2001;7:941–6. CrossRef
18.
Lee WWR. An overview of pediatric obesity. Pediatr Diabetes. 2007;8(Suppl. 9):76–87. CrossRefPubMed
19.
Urakami T, Kuwabara R, Habu M, Okuno M, Suzuki J, Takahashi S, et al. Clinical characteristics of non-obese children with type 2 diabetes mellitus without involvement of β-cell autoimmunity. Diabetes Res Clin Pract. 2013;99:105–11. CrossRefPubMed
20.
Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M, et al. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care. 2005;28:1751–6. CrossRefPubMed
21.
Tfaili H, Bacha F, Gungor N, Arslanian A. Phenotypic type 2 diabetes in obese youth; insulin sensitivity and secretion in islet-cell antibody negative vs. antibody positive patients. Diabetes. 2009;58:738–44. CrossRef
22.
Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. J Am Med Assoc. 2007;297:2716–24. CrossRef
23.
Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al. For the TODAY study group. The prevalence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype. Results from the TODAY study. Diabetes Care. 2010;33:1970–5. CrossRefPubMedPubMedCentral
24.
Butler AE, Janson J, Bonner-Weir S, Ritzei R, Rizza RA, Butler PC. β-cell deficit and increased β-cell apoptosis in human with type 2 diabetes. Diabetes. 2003;52:102–10. CrossRefPubMed
25.
Urakami T, Miyamoto Y, Fujita H, Kitagawa T. Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease. Diabetologia. 1989;32:312–5. CrossRefPubMed
26.
Urakami T, Matsunaga H, Miyamoto Y, Owada M, Kitagawa T. Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset. Diabetes Care. 1995;18:408–13. CrossRef
27.
Urakami T, Suzuki J, Yoshida A, Saito H, Mugishima H. Incidence of children with slowly progressive form of type 1 diabetes detected by the urine glucose screening at schools in the Tokyo metropolitan area. Diabetes Res Clin Paract. 2008;80:473–6. CrossRef
28.
Urakami T. How should we treat type 2 diabetes in youth? Pediatr Endocrinol Rev. 2005;3:33–9. PubMed
29.
Tamborlan WV, Haymond MW, Dunger D, Shankar R, Gubitosi-Klung R, Bethin K, et al. Expanding treatment options with type 2 diabetes: current problems and proposed solutions. A white paper from the NICHD diabetes working group. Diabetes Care. 2016;39:323–9. CrossRef